Colgate-Palmolive Company 🇺🇸
CL • Healthcare • USA
💡 Institutional Quantitative Investment Thesis
High-quality compounder passing 7/9 fundamental checks. Strong balance sheet with Forward PER compression (24.6x vs 37.6x) and robust Free Cash Flow generation.
📊 Frequently Asked Questions & Related Moat Stocks
1. What is Colgate-Palmolive Company (CL)'s Economic Moat Score in 2026?
In 2026, Colgate-Palmolive Company (CL) holds a proprietary MoatPicks Economic Moat Score™ of 68.0/100 (Narrow-to-Wide Moat). This 12-point fundamental audit evaluates CL's 60.6% gross margin, $3.4B free cash flow generation, +4.6% YoY revenue growth, and 1.5x Debt/EBITDA ratio. You can benchmark any stock's competitive durability interactively with our Economic Moat Score™ Checker.
2. Is CL stock undervalued right now based on P/E and PEG ratio?
Colgate-Palmolive Company (CL) trades near fair institutional value with a Forward P/E of 24.6x and a PEG ratio of 1.37x, supported by +4.6% YoY revenue growth. At a share price of $96.56, investors can stress-test CL's fair value using the MoatPicks Economic Moat Score™ Checker and FIRE compounding calculators. Model how compounding CL fits your long-term retirement target in our FIRE Financial Independence Calculator.
3. Which superinvestors and 13F hedge funds own CL stock?
Colgate-Palmolive Company (CL) is actively monitored across our 25 tracked 13F superinvestor portfolios and institutional quality screens. Institutional capital focuses on CL's 60.6% gross margin, $3.4B free cash flow, and 1.5x Debt/EBITDA balance sheet.